Nitronal (Glyceryl Trinitrate)

Glyceryl Trinitrate, the active ingredient in Nitronal, is an organic nitrate presented as an intravenous solution for intravenous use. It provides rapid vasodilation to relieve acute angina pectoris, manage acute coronary syndrome, and support patients with heart failure by reducing myocardial oxygen demand. GNH USA supplies Nitronal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Nitronal is an organic nitrate used in the management of acute coronary conditions and heart failure. - Acute angina pectoris: provides rapid relief of chest pain by decreasing myocardial oxygen demand. - Acute coronary syndrome: stabilises ischemic myocardium through prompt vasodilation. - Heart failure: improves cardiac output by reducing preload and afterload.

Nitronal may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: throbbing pain often triggered by vasodilation. - Hypotension: drop in blood pressure, especially with rapid infusion. - Flushing: warm sensation and reddening of skin. - Dizziness or light‑headedness. - Tachycardia: compensatory increase in heart rate. - Nausea or vomiting.

Serious or Rare Side Effects: - Severe hypotension leading to syncope. - Myocardial infarction due to coronary steal. - Methemoglobinemia causing impaired oxygen delivery. - Allergic reactions such as rash, pruritus, or anaphylaxis. - Cyanosis from profound vasodilation. - Life‑threatening arrhythmias.

Before initiating Nitronal therapy, clinicians should consider several safety measures. - Blood pressure monitoring: measure baseline and ongoing BP to avoid excessive hypotension. - Concurrent nitrate therapy: avoid additive vasodilatory effects. - Phosphodiesterase‑5 inhibitors: contraindicated because of risk of profound hypotension. - Cardiac surgery: discontinue prior to operative procedures to prevent hemodynamic instability. - Renal or hepatic impairment: increase vigilance as drug clearance may be altered. - Store at room temperature: keep in original container, protect from light and moisture.

Nitronal interacts with several drug classes that can modify its hemodynamic effects.

Major Interactions (Avoid): - Sildenafil and other PDE5 inhibitors: may cause severe hypotension. - Other organic nitrates: additive vasodilation leading to dangerous blood pressure fall. - Potent antihypertensives (e.g., beta‑blockers, calcium channel blockers): risk of excessive hypotension.

Moderate Interactions (Monitor Closely): - General antihypertensive agents: monitor blood pressure during co‑administration. - Diuretics: may enhance hypotensive response. - Alcohol: can increase vasodilatory effect and dizziness.